News & Events

Stay Current!

Integral to your Xentria journey is being informed about developments that matter to you.

Bookmark and visit this page to stay up to date.

  • All Posts
  • Happenings
  • Events
  • Pipeline
  • Xentria Insights
Xentria Advances XTMAB16 Study in Pulmonary Sarcoidosis with Completed Enrollment and Key Conference Selections
Pipeline

Xentria Advances XTMAB16 Study in Pulmonary Sarcoidosis with Completed Enrollment and Key Conference Selections

March 18, 2025
Expanding Horizons: Xentria Achieves Milestone Success with Biosimilar Development
Pipeline

Expanding Horizons: Xentria Achieves Milestone Success with Biosimilar Development

January 8, 2025
Xentria Announces Exclusive Licensing Agreement with New York University to Advance a Disease-Modifying Cardiovascular Therapy Globally
Pipeline

Xentria Announces Exclusive Licensing Agreement with New York University to Advance a Disease-Modifying Cardiovascular Therapy Globally

December 19, 2024
Navigating Innovation: Xentria’s Journey of Growth and Collaboration in Biotech
Xentria Insights

Navigating Innovation: Xentria’s Journey of Growth and Collaboration in Biotech

November 8, 2024
Clinical Trial Diversity: What We Learn and What We Do
Xentria Insights

Clinical Trial Diversity: What We Learn and What We Do

May 20, 2024
5 Ways Xentria Serves Life Sciences
Xentria Insights

5 Ways Xentria Serves Life Sciences

April 7, 2024
2023 Year in Review
Happenings

2023 Year in Review

December 19, 2023
Xentria's XTMAB-16 Receives Orphan Drug Designation from European Medicines Agency as First Patient Is Enrolled in Study
Pipeline

Xentria's XTMAB-16 Receives Orphan Drug Designation from European Medicines Agency as First Patient Is Enrolled in Study

November 15, 2023
Celebrating 40 Years of Orphan Drug Innovation
Happenings

Celebrating 40 Years of Orphan Drug Innovation

October 25, 2023
Viewpoint Project: Future of Healthcare - Innovative solutions
Happenings

Viewpoint Project: Future of Healthcare - Innovative solutions

July 27, 2023
Xentria’s Feature in Nature Biopharma Dealmakers
Happenings

Xentria’s Feature in Nature Biopharma Dealmakers

July 11, 2023
Licensing Agreement to Commercialize XTMAB-16 in Sarcoidosis
Pipeline

Licensing Agreement to Commercialize XTMAB-16 in Sarcoidosis

June 27, 2023
ATS 2023: Join Us at our Clinical Trial Awareness Booth CT14 Hall D
Events

ATS 2023: Join Us at our Clinical Trial Awareness Booth CT14 Hall D

May 2023
Xentria Announces Peer Reviewed Publication of Biosim Model in Front. Pharmacol.
Happenings

Xentria Announces Peer Reviewed Publication of Biosim Model in Front. Pharmacol.

March 21, 2023
Xentria Announces $25 Million Financing Round to Advance Pipeline & Execute Growth Strategy
Pipeline

Xentria Announces $25 Million Financing Round to Advance Pipeline & Execute Growth Strategy

October 18, 2022
Xentria Appoints Lead Scientific Advisor & Chief Operating Officer
Happenings

Xentria Appoints Lead Scientific Advisor & Chief Operating Officer

August 4, 2022
FSR 2022 Global Virtual Patient Summit
Events

FSR 2022 Global Virtual Patient Summit

July 2022
Xentria Shares Initial Findings of Novel Biologic XTMAB-16’s Potential to Reduce Sarcoidosis Granuloma
Pipeline

Xentria Shares Initial Findings of Novel Biologic XTMAB-16’s Potential to Reduce Sarcoidosis Granuloma

June 24, 2022
American Thoracic Society (ATS) International Conference 2022
Events

American Thoracic Society (ATS) International Conference 2022

May 13-18, 2022
Xentria to Present Initial Preclinical Findings of XTMAB-16 at ATS 2022 International Conference
Happenings

Xentria to Present Initial Preclinical Findings of XTMAB-16 at ATS 2022 International Conference

March 8, 2022
The Balancing Act Presents Behind the Mystery
Events

The Balancing Act Presents Behind the Mystery

December 2021
Xentria Highlights New Episode Of Lifetime® TV’s “Behind The Mystery” Segment Of “The Balancing Act®” On Sarcoidosis
Happenings

Xentria Highlights New Episode Of Lifetime® TV’s “Behind The Mystery” Segment Of “The Balancing Act®” On Sarcoidosis

December 6, 2021
WASOG/AASOG 2021: Multidisciplinary Meeting for Sarcoidosis and ILD
Events

WASOG/AASOG 2021: Multidisciplinary Meeting for Sarcoidosis and ILD

November 29 - December 2 2021
FSR 2021 Clinical Engagement Conference
Events

FSR 2021 Clinical Engagement Conference

October 2nd 2021
Xentria Initiates Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis
Pipeline

Xentria Initiates Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

June 22, 2021
FSR 2021 Virtual Patient Education Summit
Events

FSR 2021 Virtual Patient Education Summit

June 2021
NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business
Happenings

NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business

May 20, 2021
Xentria Patient Focus Group: Living with Sarcoidosis
Events

Xentria Patient Focus Group: Living with Sarcoidosis

April 2021
Xentria Submits IND Application for XTMAB-16 in the Treatment of Sarcoidosis
Pipeline

Xentria Submits IND Application for XTMAB-16 in the Treatment of Sarcoidosis

March 3, 2021
Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis
Pipeline

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

December 15, 2020

No articles found. Please try a different category.

Contact Us